Azolylacylguanidines as β-secretase inhibitors
US7488832B2 · kind B2 · utility
19Cited by
8References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2006 |
| Grant date | Feb 10, 2009 |
| Priority date | — |
| Expiry date | Feb 13, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides an azolylacylquanidine compound of formula IThe present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.